RJFSA
AGN

Raymond James Financial Services Advisors’s Allergan plc AGN Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,583
Closed -$3.12M – 2946
2020
Q1 		$3.12M Sell
17,583
-13,395
-43% -$2.52M 0.01% 693
2019
Q4 		$5.92M Sell
30,978
-572
-2% -$103K 0.02% 674
2019
Q3 		$5.31M Sell
31,550
-3,357
-10% -$547K 0.02% 673
2019
Q2 		$5.84M Sell
34,907
-8,789
-20% -$1.22M 0.02% 621
2019
Q1 		$6.4M Buy
43,696
+2,396
+6% +$347K 0.03% 566
2018
Q4 		$5.52M Buy
41,300
+2,067
+5% +$339K 0.03% 497
2018
Q3 		$7.47M Buy
39,233
+4,004
+11% +$736K 0.03% 498
2018
Q2 		$5.87M Buy
35,229
+4,275
+14% +$686K 0.03% 541
2018
Q1 		$5.21M Sell
30,954
-32,519
-51% -$5.45M 0.03% 533
2017
Q4 		$10.4M Sell
63,473
-16,454
-21% -$2.95M 0.06% 341
2017
Q3 		$16.4M Buy
79,927
+4,493
+6% +$1.04M 0.1% 222
2017
Q2 		$18.3M Buy
75,434
+3,752
+5% +$882K 0.13% 192
2017
Q1 		$17.1M Buy
71,682
+11,515
+19% +$2.68M 0.13% 183
2016
Q4 		$12.6M Buy
60,167
+1,694
+3% +$351K 0.11% 235
2016
Q3 		$13.5M Sell
58,473
-4,357
-7% -$1.06M 0.12% 206
2016
Q2 		$14.5M Buy
62,830
+16,619
+36% +$3.83M 0.14% 186
2016
Q1 		$12.4M Sell
46,211
-3,613
-7% -$1.03M 0.14% 178
2015
Q4 		$15.6M Buy
+49,824
New +$14.8M 0.18% 140
2013
Q3 		– Sell
-10,638
Closed -$1.34M – 1010
2013
Q2 		$1.34M Buy
+10,638
New +$1.2M 0.04% 512

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Raymond James Financial Services Advisors's AGN Position: Q2 2020 in Review

Raymond James Financial Services Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 17,583 shares — an estimated $3.12M sold.

Raymond James Financial Services Advisors first reported a position in AGN in Q2 2013 and held it in 19 quarters. The position peaked at $18.3M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Raymond James Financial Services Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 17,583 Allergan plc shares in Q2 2020, an estimated $3.12M.
  • Raymond James Financial Services Advisors first reported a position in Allergan plc in Q2 2013 and held it in 19 quarters.
  • Raymond James Financial Services Advisors's Allergan plc position peaked at $18.3M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.